| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0099 | 0.9 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |